3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide

C31H53N9O14 — CID 71155507

IUPAC3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide
SMILESCC(C)C1CC(=O)C(CO)NC(=O)C(CNC(=O)C(C)C(C)N)NC(=O)CNC(=O)C(O)CNC(=O)C(C(C)O)NC(=O)C(C(O)C(O)C(N)=O)NC1=O
InChIInChI=1S/C31H53N9O14/c1-11(2)15-6-18(43)17(10-41)38-28(51)16(7-34-26(49)12(3)13(4)32)37-20(45)9-36-29(52)19(44)8-35-30(53)21(14(5)42)39-31(54)22(40-27(15)50)23(46)24(47)25(33)48/h11-17,19,21-24,41-42,44,46-47H,6-10,32H2,1-5H3,(H2,33,48)(H,34,49)(H,35,53)(H,36,52)(H,37,45)(H,38,51)(H,39,54)(H,40,50)
InChIKeyQOITXAYQBHICFX-UHFFFAOYSA-N
MW775.81 g/mol
LogP-8.56
Rot. Bonds10

About 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide

3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide (PubChem CID 71155507) has the molecular formula C31H53N9O14 and a molecular weight of 775.81 g/mol. Its IUPAC name is 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide.

Molecular Properties

Compound Name3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide
PubChem CID71155507
Molecular FormulaC31H53N9O14
Molecular Weight775.81 g/mol
Exact Mass775.37
IUPAC Name3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide
SMILESCC(C)C1CC(=O)C(CO)NC(=O)C(CNC(=O)C(C)C(C)N)NC(=O)CNC(=O)C(O)CNC(=O)C(C(C)O)NC(=O)C(C(O)C(O)C(N)=O)NC1=O
InChIInChI=1S/C31H53N9O14/c1-11(2)15-6-18(43)17(10-41)38-28(51)16(7-34-26(49)12(3)13(4)32)37-20(45)9-36-29(52)19(44)8-35-30(53)21(14(5)42)39-31(54)22(40-27(15)50)23(46)24(47)25(33)48/h11-17,19,21-24,41-42,44,46-47H,6-10,32H2,1-5H3,(H2,33,48)(H,34,49)(H,35,53)(H,36,52)(H,37,45)(H,38,51)(H,39,54)(H,40,50)
InChIKeyQOITXAYQBHICFX-UHFFFAOYSA-N
XLogP-8.56
TPSA391.03 Ų
H-Bond Donors14
H-Bond Acceptors15
Rotatable Bonds10
Heavy Atoms54
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500775.81
LogP ≤ 5-8.56
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1015

Analyze 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide?
The IUPAC name of 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide (CID 71155507) is 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide.
What is the SMILES notation for 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide?
The canonical SMILES for 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide is CC(C)C1CC(=O)C(CO)NC(=O)C(CNC(=O)C(C)C(C)N)NC(=O)CNC(=O)C(O)CNC(=O)C(C(C)O)NC(=O)C(C(O)C(O)C(N)=O)NC1=O.
What is the InChIKey of 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide?
The InChIKey is QOITXAYQBHICFX-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H53N9O14/c1-11(2)15-6-18(43)17(10-41)38-28(51)16(7-34-26(49)12(3)13(4)32)37-20(45)9-36-29(52)19(44)8-35-30(53)21(14(5)42)39-31(54)22(40-27(15)50)23(46)24(47)25(33)48/h11-17,19,21-24,41-42,44,46-47H,6-10,32H2,1-5H3,(H2,33,48)(H,34,49)(H,35,53)(H,36,52)(H,37,45)(H,38,51)(H,39,54)(H,40,50).
What are the key properties of 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide?
3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide has a molecular weight of 775.81 g/mol, XLogP of -8.56, 10 rotatable bonds, 14 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-N-[[16-(3-amino-1,2-dihydroxy-3-oxopropyl)-9-hydroxy-13-(1-hydroxyethyl)-22-(hydroxymethyl)-2,5,8,12,15,18,21-heptaoxo-19-propan-2-yl-1,4,7,11,14,17-hexazacyclodocos-3-yl]methyl]-2-methylbutanamide is sourced from PubChem (CID 71155507), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).